deepull appoints Didier Deltort to its Board of Directors
May 22, 2024 03:00 ET
|
DeepUll
deepull appoints Didier Deltort to its Board of Directors Barcelona, Spain – 22 May 2024 – deepull, a medical diagnostics company developing culture-free diagnostic solutions for rapid pathogen...
deepull unveils 1 hour, direct-from-blood multiplex PCR test for 95% of sepsis-causing pathogens at ESCMID 2024
April 25, 2024 03:00 ET
|
DeepUll
deepull unveils 1 hour, direct-from-blood multiplex PCR test for 95% of sepsis-causing pathogens at ESCMID 2024 UllCORE is designed to transform life-saving clinical decision making for sepsis...
deepull appoints Kimberle Chapin, MD, as Chief Medical Officer and Wade Stevenson as Chief Marketing and Sales Officer
April 18, 2024 02:00 ET
|
DeepUll
deepull appoints Kimberle Chapin, MD, as Chief Medical Officer and Wade Stevenson as Chief Marketing and Sales Officer Kimberle Chapin brings significant expertise in microbiology and infectious...
Spain: EUR 20 million EIB loan to DeepUll accelerates early detection and diagnosis of Sepsis
December 13, 2022 03:30 ET
|
DeepUll
PRESS RELEASE Luxembourg, 13th December 2022 Spain: EUR 20 million EIB loan to DeepUll accelerates early detection and diagnosis of Sepsis The EIB and...
DeepUll raises €13M Series B financing to progress early sepsis recognition platform
October 20, 2022 01:00 ET
|
DeepUll
DeepUll raises €13M Series B financing to progress early sepsis recognition platformFinancing led by new investors Innvierte and an undisclosed strategic investor with participation from existing...
DeepUll Appoints Richard Ivey to its Board of Directors
October 04, 2021 07:00 ET
|
DeepUll
DeepUll Appoints Richard Ivey to its Board of Directors Diagnostics industry veteran with forty years’ experience to support DeepUll in its continued development of its early sepsis identification...
DeepUll Appoints Richard Ivey to its Board of Directors
October 04, 2021 02:00 ET
|
DeepUll
DeepUll Appoints Richard Ivey to its Board of Directors Diagnostics industry veteran with forty years’ experience to support DeepUll in its continued development of its early sepsis identification...